Johnson & Johnson Reports 2018 Third-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Johnson & Johnson (JNJ) PT Raised to $150 at RBC Capital
October 17, 2018 7:49 AM EDTRBC Capital analyst Glenn Novarro raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $143.00) while maintaining an Outperform rating following Q3 results.
Novarro notes Pharma excelled again, and the Devices & Consumer segments are heading in the right direction.
The... More
Johnson & Johnson (JNJ) Tops Q3 EPS by 2c, Updates FY Guidance
October 16, 2018 6:41 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.05, $0.02 better than the analyst estimate of $2.03. Revenue for the quarter came in at $20.3 billion versus the consensus estimate of $20.03 billion.
GUIDANCE:
Johnson & Johnson sees FY2018 EPS of $8.13-$8.18, versus the consensus of... More
